New diabetes pill tested for better blood sugar control

NCT ID NCT00971243

Completed Disease control Sponsor: Tanabe Pharma Corporation Source: ClinicalTrials.gov ↗

Summary

This study tested whether adding a new drug called MP-513 to the common diabetes medication metformin could help control blood sugar levels better. It involved 448 adults with type 2 diabetes who were already taking metformin. Researchers compared four different doses of MP-513 over 24 weeks, with some patients continuing for up to a year, to find the safest and most effective dose.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Study site

Aalborg, Denmark
Study site

Ballerup Municipality, Denmark
Study site

Vejle, Denmark
Study site

Falkensee, Germany
Study site

Hamburg, Germany
Study site

Karlsruhe, Germany
Study site

Kiel, Germany
Study site

Ludwigshafen, Germany
Study site

Lübeck, Germany
Study site

Mainz, Germany
Study site

Ádám, Hungary
Study site

Békéscsaba, Hungary
Study site

Budapest, Hungary
Study site

Gyöngyös, Hungary
Study site

Kaposvár, Hungary
Study site

Miskolc, Hungary
Study site

Nyíregyháza, Hungary
Study site

Semmelweis, Hungary
Study site

Szentes, Hungary
Study site

Szigetvár, Hungary
Study site

Kaunas, Lithuania
Study site

Klaipėda, Lithuania
Study site

Vilnius, Lithuania
Study site

Gdansk, Poland
Study site

Krakow, Poland
Study site

Leszno, Poland
Study site

Lodz, Poland
Study site

Niemodlin, Poland
Study site

Płock, Poland
Study site

Warsaw, Poland
Study site

Wroclaw, Poland
Study site

Brasov, Romania
Study site

Bucharest, Romania
Study site

Galati, Romania
Study site

Ploieşti, Romania
Study site

Timișoara, Romania
Study site

Timuș, Romania
Study site

Addlestone, United Kingdom
Study site

Ayr, United Kingdom
Study site

Bournemouth, United Kingdom
Study site

East Sussex, United Kingdom
Study site

Edinburgh, United Kingdom
Study site

Oldham, United Kingdom
Study site

York, United Kingdom

Conditions

Explore the condition pages connected to this study.

TYPE 2 DIABETES MELLITUS